Company Quick10K Filing
Spartannash
10-Q 2021-04-24 Filed 2021-06-03
10-K 2021-01-02 Filed 2021-03-03
10-Q 2020-10-03 Filed 2020-11-12
10-Q 2020-07-11 Filed 2020-08-13
10-Q 2020-04-18 Filed 2020-05-28
10-K 2019-12-28 Filed 2020-02-26
10-Q 2019-10-05 Filed 2019-11-07
10-Q 2019-07-13 Filed 2019-08-21
10-Q 2019-04-20 Filed 2019-05-22
10-K 2018-12-29 Filed 2019-02-27
10-Q 2018-10-06 Filed 2018-11-08
10-Q 2018-07-14 Filed 2018-08-16
10-Q 2018-04-21 Filed 2018-05-30
10-K 2017-12-30 Filed 2018-02-26
10-Q 2017-10-07 Filed 2017-11-09
10-Q 2017-07-15 Filed 2017-08-17
10-Q 2017-04-22 Filed 2017-05-25
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-10-08 Filed 2016-11-10
10-Q 2016-07-16 Filed 2016-08-18
10-Q 2016-04-23 Filed 2016-05-26
10-K 2016-01-02 Filed 2016-03-02
10-Q 2015-10-10 Filed 2015-11-12
10-Q 2015-07-18 Filed 2015-08-20
10-Q 2015-04-25 Filed 2015-05-28
10-K 2015-01-03 Filed 2015-03-04
10-Q 2014-10-04 Filed 2014-11-06
10-Q 2014-07-12 Filed 2014-08-14
10-Q 2014-04-19 Filed 2014-05-23
10-Q 2013-09-14 Filed 2013-10-24
10-Q 2013-06-22 Filed 2013-08-01
10-K 2013-03-30 Filed 2013-05-23
10-Q 2013-01-05 Filed 2013-02-14
10-Q 2012-09-15 Filed 2012-10-25
10-Q 2012-06-23 Filed 2012-08-02
10-K 2012-03-31 Filed 2012-05-23
10-Q 2011-12-31 Filed 2012-02-09
10-Q 2011-09-10 Filed 2011-10-20
10-Q 2011-06-18 Filed 2011-07-28
10-K 2011-03-26 Filed 2011-05-16
10-Q 2011-01-01 Filed 2011-02-03
10-Q 2010-09-11 Filed 2010-10-14
10-Q 2010-06-19 Filed 2010-07-29
10-K 2010-03-27 Filed 2010-05-17
10-Q 2010-01-02 Filed 2010-02-04
8-K 2020-11-11
8-K 2020-10-07
8-K 2020-09-14
8-K 2020-08-12
8-K 2020-08-04
8-K 2020-05-27
8-K 2020-05-26
8-K 2020-02-19
8-K 2019-11-06
8-K 2019-08-15
8-K 2019-08-14
8-K 2019-08-09
8-K 2019-05-29
8-K 2019-05-20
8-K 2019-05-09
8-K 2019-02-20
8-K 2019-02-06
8-K 2018-12-18
8-K 2018-11-07
8-K 2018-08-20
8-K 2018-08-15
8-K 2018-05-29
8-K 2018-05-24
8-K 2018-02-27
8-K 2018-02-21

Spartannash Financials

SPTN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-182011-09-102011-12-312012-03-312012-06-232012-09-152013-01-052013-03-302013-06-222013-09-142014-04-192014-07-122014-10-042015-01-032015-04-252015-07-182015-10-102016-01-022016-04-232016-07-162016-10-082016-12-312017-04-222017-07-152017-10-072017-12-302018-04-212018-07-142018-10-062018-12-292019-04-202019-07-132019-10-05
Cash3862552667964615686813923292426242023131617162119212023
Accounts Receivable62605759616050616059283313298320317305306322292342349370344330355364346377363374
Inventory132121121100132136134125135141558565613577563552573521533536562540540556598597578562592554596573595
PP&E2402442455572572622725872692686326075969985805885861,0605735755711,0906286225881,1835825825771,216623620618
Assets7837967887637847847957907927981,9721,9891,9911,9321,9161,9331,9661,9251,9211,9241,9941,9302,1812,1992,0342,0562,0172,0112,0541,9722,3592,2922,335
Accounts Payable130129111108128129116121130138349376411320350351366354333339399372371394441377357365411358391407457
Long-Term Debt170173130134156151171150148138598576550570516516526495523500501439684668678756747716708705778708699
Liabilities4724754624404674574654544544501,2531,2561,2471,1851,1591,1671,1881,1351,1291,1201,1781,1051,3391,3491,3281,3341,3051,2861,3181,2561,6661,6041,645
Stockholders' Equity311321327324318327329336338348720733744747757766779791791804816825841849706722712724736716694688689
Income Statement ($MM)2011-06-182011-09-102011-12-312012-03-312012-06-232012-09-152013-01-052013-03-302013-06-222013-09-142014-04-192014-07-122014-10-042015-01-032015-04-252015-07-182015-10-102016-01-022016-04-232016-07-162016-10-082016-12-312017-04-222017-07-152017-10-072017-12-302018-04-212018-07-142018-10-062018-12-292019-04-202019-07-132019-10-05
Revenue6036207976156046227905936126492,3343,4941,8101,9632,3131,7961,7751,7682,2791,8281,8001,8282,4031,8951,9071,9242,3851,8961,8871,8972,5422,6422,000
Cost of Revenue4774876344804824916294604875131,9873,0191,5481,6801,9761,5341,5161,5101,9451,5651,5451,5692,0451,6241,6451,6692,0421,6301,6311,6512,1651,7071,709
Gross Profit125133163135122130161133125136347476261282336262259258334263255259357271262255343266256245378289290
R&D
SG&A111113150115110111149113114118315229228250302225225223296223220224323231228232309236229360266273
Tax5636-36253681211371291061197712-76-225523-3-2
Net Income610510611385111220171210201517101717131521-12435121817-147-7-0
Cash Flow ($MM)2011-06-182011-09-102011-12-312012-03-312012-06-232012-09-152013-01-052013-03-302013-06-222013-09-142014-04-192014-07-122014-10-042015-01-032015-04-252015-07-182015-10-102016-01-022016-04-232016-07-162016-10-082016-12-312017-04-222017-07-152017-10-072017-12-302018-04-212018-07-142018-10-062018-12-292019-04-202019-07-132019-10-05
Cash Operating736943-1920263272033315322497909462476-104933-19604438149036
Cash Investing-10-11-12-11-7-12-27-8-9-8-22-14-18-27-5-50-17-24-13-23-17-16-233-15-29-38-21-17-87-15-15
Cash Financing-2-0-4-615-72-270-10-4-26-344-42-105-6011-28-4-62238-31-1360-38-1677-76-18